Page last updated: 2024-12-06
thioridazine-5-sulfoxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
thioridazine-5-sulfoxide: metabolite of thioridazine; cardiotoxic; RN given refers to parent cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 24494 |
CHEMBL ID | 3544852 |
MeSH ID | M0122148 |
Synonyms (21)
Synonym |
---|
10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-, 5-oxide |
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine 5-oxide |
thioridazine 5-oxide |
thioridazine sulfoxide |
yi69b9mw63 , |
unii-yi69b9mw63 |
7776-05-8 |
thioridazine-5-oxide |
thioridazine-5-sulfoxide |
FT-0675191 |
thioridazine 5-sulfoxide |
thioridazine hydrochloride impurity c [ep impurity] |
thioridazine sulphoxide |
10-(2-(1-methylpiperidin-2-yl)ethyl)-2-methylsulfanylphenothiazine 5-oxide |
thioridazine impurity c [ep impurity] |
CHEMBL3544852 |
10-[2-[(2rs)-1-methylpiperidin-2-yl]ethyl]-2-(methylsulfanyl)-10h-phenothiazine 5-oxide (thioridazine 5-sulfoxide) |
Q27294535 |
DTXSID80998951 |
10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-5lambda~4~-phenothiazin-5(10h)-one |
thioridazine 5-sulfoxide(mixture of diastereomers) |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" Thioridazine-5-sulphoxide, N-desmethylthioridazine-5-sulphoxide and thioridazine-N-oxide diastereoisomers were found to be thioridazine metabolites following dosing in rats or after in-vitro incubation with rat liver homogenate." | ( Chromatographic separation of thioridazine sulphoxide and N-oxide diastereoisomers: identification as metabolites in the rat. Buckley, DG; Curry, SH; Watkins, GM; Whelpton, R, 1986) | 0.27 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (55.56) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 11.52
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.52) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (7.69%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 12 (92.31%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |